Gestational Diabetes and the Link to Cardiovascular Disease: What You Need to Know

Gestational diabetes (GD) is a temporary form of diabetes that develops during pregnancy. While it typically resolves after childbirth, research increasingly highlights the long-term health implications of GD, particularly the increased risk of cardiovascular disease (CVD).

The Evidence: How GD Increases CVD Risk

Multiple studies have demonstrated a clear association between GD and an elevated risk for various CVDs. A recent meta-analysis of 38 studies involving nearly 78 million participants revealed an increased risk of heart failure, arrhythmias, coronary artery disease, peripheral artery disease, angina pectoris, and ischemic stroke/TIA in women who experienced GD.³

A 2024 longitudinal study of over 84,000 pregnancies further confirmed this link, showing a greater risk of new-onset chronic hypertension within two years postpartum for women with GD compared to those without.² Moreover, a previous cohort study of nearly 900,000 women found a 2.4-fold increase in CVD risk for those with both gestational hypertensive disorder and GD compared to those with GD alone.⁵

The dangers extend beyond diabetes. Research published in 2024 in *JACC: Advances* found that women with a history of GD have a higher risk of adverse changes in cardiac structure, function, and endothelial dysfunction within a decade after delivery. These risks may be partly driven by the development of prediabetes or type 2 diabetes.⁶

Understanding the Mechanisms

It was previously unclear whether the increased CVD risk after GD stemmed from GD itself or the subsequent development of type 2 diabetes. However, recent findings indicate that the CVD risk associated with GD persists even when normoglycemia is achieved after pregnancy.⁷ This suggests a direct link and highlights the importance of early intervention and ongoing cardiovascular management.

Racial Disparities in GD and CVD

Black women are disproportionately affected by GD and other pregnancy complications, including preeclampsia and increased maternal mortality rates.^8,9 Limited access to prenatal and postpartum care further exacerbates their risk for adverse outcomes.¹⁰ Addressing these disparities requires a multi-faceted approach, including greater awareness among clinicians, culturally appropriate care, and targeted interventions to improve access to healthcare for Black women.

Preventing CVD After GD

Early detection and management are crucial for reducing the long-term CVD risk associated with GD.

• Preconceptual Counseling: For women not yet pregnant, identifying cardiovascular risk factors like hypertension allows for early interventions to lower the risk of both GD and future CVD.
• Postpartum Screening: Frequent screening for diabetes, dyslipidemia, and hypertension in the years after delivery is essential for identifying modifiable CVD risk factors early on.
• Lifestyle Modifications: Encouraging a heart-healthy diet and regular exercise can significantly reduce CVD risk.
• Medication Management: Some patients may require medication to control blood pressure or cholesterol.

Overcoming barriers to care, such as busy schedules and limited access to healthcare, is crucial to ensure ongoing medical support for women with GD.

Comorbid GD and CVD: Added Challenges

Managing GD alongside pre-existing CVD presents unique challenges for both mother and baby. Balancing blood sugar control with cardiovascular health requires careful consideration, especially during pregnancy and breastfeeding.

While medications like SGLT2 inhibitors and GLP-1 receptor agonists offer cardiovascular benefits, they are contraindicated during pregnancy and breastfeeding. GD treatment typically involves insulin therapy or metformin, along with meticulous blood sugar monitoring, dietary adjustments, and collaborative care between obstetricians, endocrinologists, and cardiologists.

Key Remaining Needs

Addressing the GD-CVD connection requires continued efforts in several key areas:

• Clinician Education: Increasing awareness among healthcare providers about the link between GD and CVD, especially in Black women, is paramount for effective patient care and early intervention.
• Research on Racial Disparities: Investigating the social, genetic, and environmental factors driving racial disparities in GD is crucial for developing targeted solutions.
• Novel Therapies: **Developing targeted therapies to mitigate the CVD risk in the years following delivery is crucial for closing the window of increased vulnerability.
• Prevention Strategies: Research on approaches to prevent GD itself is essential for reducing the long-term health burden this condition poses.